Xcout Intel
GRAYBUG VISION, INC. competitors & alternatives
The 12 closest competitors and alternatives to GRAYBUG VISION, INC. among biotechnology companies — ranked by similarity to what GRAYBUG VISION, INC. actually does, not by market-cap band.
Subscribe to see GRAYBUG VISION, INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About GRAYBUG VISION, INC.
Graybug Vision, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, with additional offices in Baltimore, Maryland, focused on developing medicines for ocular diseases.
GRAYBUG VISION, INC. at a glance
GRAYBUG VISION, INC. is a biotechnology company headquartered in United States. It has raised at least $99.5M across the 2 funding rounds on record. Its most recent funding round raised $55M in July 2019. Xcout tracks 1 named person at GRAYBUG VISION, INC., including Nguyễn Văn Chung (Chịu trách nhiệm nội dung).
GRAYBUG VISION, INC. leadership
- Nguyễn Văn ChungChịu trách nhiệm nội dung
GRAYBUG VISION, INC. funding rounds
At least $99.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $55M | — | |
| Series B | $44.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 GRAYBUG VISION, INC. competitors
Ranked by semantic similarity — how close each company is to GRAYBUG VISION, INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Similar biotechnology company
Broadwing Bio is a biotechnology company that develops antibody-based therapies to treat major causes of adult vision loss, specifically focusing on Geographic Atrophy and Glaucoma. The company utilizes genetics-driven insights to target ocular diseases and preserve vision for patients.
Biotech
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to developing treatments that preserve the sight of individuals impacted by severe eye diseases.
Similar biotechnology company
Stargazer Pharmaceuticals, Inc. is a Boston-based biopharmaceutical company focused on developing novel treatments for rare eye diseases, including Stargardt disease. The company advances clinical-stage pharmaceutical candidates through specialized clinical trials.
Similar biotechnology company
SparingVision is a genomic and gene therapy medicines company translating pioneering science into vision-saving treatments, with US headquarters located in Boston, Massachusetts.
Similar biotechnology company
Memento Medicines, Inc. is a privately held biotechnology company headquartered in Boston, Massachusetts, focused on developing novel biologic therapies for retinal diseases.
Similar biotechnology company
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Similar biotechnology company
OcuCure Therapeutics, Inc. is an ophthalmic pharmaceutical company located in Virginia that focuses on developing new proprietary drugs at the intersection of medical research and healthcare solutions.
Life Sciences (Therapeutics)
MediPrint Ophthalmics is a clinical-stage eye care pharmaceutical company that develops and commercializes a proprietary ocular drug delivery portfolio. The company provides drug-eluting, comfort-enhancing contact lenses designed to offer continuous medication delivery and vision correction for patients with ocular diseases.
Similar biotechnology company
ONL Therapeutics, Inc. is a clinical-stage biopharmaceutical company located in Michigan, United States, focused on the development of novel therapies for retinal diseases.
Similar biotechnology company
Eyebiotech Ltd is a clinical-stage biotechnology company headquartered in London, United Kingdom. Founded in 2021, the company focuses on developing novel therapies for ophthalmology and ocular diseases.
Similar biotechnology company
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of GRAYBUG VISION, INC. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for GRAYBUG VISION, INC.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →